Advertisement

Prevalence of head and neck cancers in Ahmedabad, Gujarat

  • Jagruti A. PatelEmail author
  • Forum G. Shah
  • Jagdish M. Kothari
  • Kaustubh D. Patel
Main Article

Abstract

Introduction

Head and neck cancer constitute one of the commonest cancers in India. Use of smokeless tobacco (pan masala, gutka, zarda, etc.) is the maximum in Gujarat, especially in and around Ahmedabad, and it is responsible for a large majority of these cancers.

Aim and objective

The present study was carried out to study the patient’s characteristics, prevalence, treatment modalities and histopathological subtypes of head and neck cancer in and around Ahmedabad.

Methods

A cross-sectional and observational study was carried out at the Head and Neck Services Department of Aastha Oncology Associates, Medi-Surge Hospitals, Ahmedabad, from December 2006 to May 2007. Patients were made to fill up the Case Record Form (CRF) with their informed consent. Proforma of the CRF included patient’s age, gender, income, education, family history, lifestyle, signs and symptoms, various investigations, treatment options and adverse effects during treatment and follow up. Preponderance of cancer was found in males (86%) with maximum prevalence in age group 41–60 years (69%). 58% cases were habitual tobacco chewers. Majority of head and neck cancers constituted the tongue, buccal mucosa and alveolus cancers. Radiotherapy and surgery were major treatment options in 44% patients. Blood parameters profile in all the three treatment groups was found to be lower than the control group.

Conclusion

We conclude that a properly structured and site specific data like this pin points to the magnitude and pattern of head and neck cancer problem in India and it can augment the National Cancer Registry Program.

Keywords

Head and neck cancer Radiotherapy Chemotherapy Prevalence 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Stupp R, Vokes EE (2003) Head and Neck tumors. In, Vokes EE, Golomb HM (ed.). Oncologic therapies, 2nd edition. Chicago: Springer Verlag, 357–374Google Scholar
  2. 2.
    National Cancer Registry Programme-Biennial Report (1988–89) of the National Cancer Registry Programme. New Delhi; Indian Council of Medical Research, Surya Printers, 1992; 3–42Google Scholar
  3. 3.
    Spitz MR, Fueger JJ, Goepfert H, Hong WK, Newell RR (1998) Squamous cell carcinoma of the upper aerodigestive tract: A case comparison analysis. Cancer 61:203–208CrossRefGoogle Scholar
  4. 4.
    Mehrotra R, Yadav S (2006) Oral Squamous cell carcinoma: Etiology, pathogenesis and prognostic value of genomic alterations. Ind J Cancer 43:60–66Google Scholar
  5. 5.
    Viswanathan H, Wilson JA (2004) Alcohol–the neglected risk factor in head and neck cancer. Clinical Otolaryngol 29:295–300CrossRefGoogle Scholar
  6. 6.
    Garden AS, Harris J, Vokes EE, Forastiere AA, Ridge JA, Jones C, et al. (2004) Preliminary results of Radiation Therapy Oncology Group 97-03: A randomized Phase II trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. J Clin Oncol 22:2856–2864PubMedCrossRefGoogle Scholar
  7. 7.
    Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, et al. (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer, N Eng J Med 349:2091–2098CrossRefGoogle Scholar
  8. 8.
    Brockstein B, Haraf DJ, Rademaker AW, Kies MS, Stenson KM, Rosen F, et al. (2004) Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: A 9 year, 337 patients, multi-institutional experience. Ann Oncol 15:1179–1186PubMedCrossRefGoogle Scholar
  9. 9.
    Argiris A, Brockstein BE, Haraf DJ, Stenson KM, Mittal BB, Kies MS, et al. (2004) Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy. Clin Cancer Res 10:1956–1962PubMedCrossRefGoogle Scholar
  10. 10.
    National Cancer Institute, US National Institute of Health, Surveillance, Epidemiology and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence-SEER (1973–2003) 2006;1–4Google Scholar
  11. 11.
    Sankaranarayanan R, Masuyer E, Swaminathan R, Ferlay J, Whelan S (1998) Head and Neck Cancer: a global perspective on epidemiology and prognosis. Anticancer Res 18:4779–4786PubMedGoogle Scholar
  12. 12.
    Mehrotra R, Singh M, Gupta RK, Singh M, Kapoor AK (2005) Trends of prevalence and pathological spectrum of head and neck cancers in North India. Ind J Cancer 42:89–93Google Scholar
  13. 13.
    Iyer SP, Gore MA, Subramaniyan P, Tengse S (2004) Head, Face and Neck Malignancy: Impact of stage at presentation. Bombay Hospital Journal 48:298–304Google Scholar
  14. 14.
    Taneja C, Allen H, Koness RJ, Radie-Keane K and Wancho HJ (2002) Changing patterns of failure of Head and Neck Cancer. Arch Otolaryngol Head Neck Surg 128:324–327PubMedGoogle Scholar
  15. 15.
    Parija UR (2006) Oral oncology. Proceedings of the international congress on oral cancers; 1:14–18Google Scholar
  16. 16.
    Pytnyia KB, Grant JR, Etzel CJ, Roberts DB, Wei Q, Sturgis EM, et al. (2004) Matched pair analysis of survival of never smokers and ever smokers with squamous cell carcinoma of the head and neck. J Clin Oncol 22:3981–3988CrossRefGoogle Scholar
  17. 17.
    Talamani R, Bosetti C, La Vecchia C, Maso LD, Levi F, Bidoli E, et al. (2002) Combined effect of tobacco and alcohol on laryngeal cancer risk: a case control study. Cancer causes control 13:957–964CrossRefGoogle Scholar
  18. 18.
    Gupta PC (2001) The public health impact of tobacco. Curr Sci 81:475–481Google Scholar
  19. 19.
    Villaret DB, Wang T, Dillon D, Xu J, Sivam D, Cheever MA et al. (2000) Identification of genes over expression in head and neck squamous cell carcinoma using a scombination of complementary DNAnsubtraction and mircoarray analysis. Larynogscope 110:374–381CrossRefGoogle Scholar
  20. 20.
    Brachman DG (1997) Molecular biology of Head and Neck Cancer. Semin Oncol 21:321–329Google Scholar
  21. 21.
    Mendenhall WM, Morris CG, Amdur RJ, Werning JW, Villaret DB (2005) Radiotherapy alone or combined with surgery for salivary gland carcinoma. Cancer 103:2544–2550PubMedCrossRefGoogle Scholar
  22. 22.
    Yogi V, Singh OP (2005) Induction followed with concurrent chemo radiotherapy in advanced head and neck cancer. J Can Res Ther 1:198–203CrossRefGoogle Scholar
  23. 23.
    Vera-Llonch M, Oster G, Hagiwara M, Sonis S (2006) Oral Mucositis in Patients Undergoing Radiation Treatment for Head and Neck Carcinoma-Risk factors and clinical consequences. Cancer 106:329–336PubMedCrossRefGoogle Scholar
  24. 24.
    Dubray B, Mosseri V, Brunin F, Jaulerry C, Poncet P, Rodriguez J, et al. (1996) Anemia Is Associated with Lower Local-Regional Control and Survival after Radiation Therapy for Head and Neck Cancer: A Prospective Study. Radiol 201:553–558Google Scholar
  25. 25.
    Yeole BB, Sankaranarayanan R, Sunny M Sc L, Swaminathan R, Parkin DM (2000) Survival from head and neck cancer in Mumbai (Bombay), India. Bombay Cancer Registry Indian Cancer Society, Mumbai (Bombay), India. Cancer 89:437–444PubMedCrossRefGoogle Scholar
  26. 26.
    Bhattacharjee A, Chakraborty A, Purkaystha P (2006) Prevalence of head and neck cancers in the north east- an institutional study. Indian J Otolaryngol Head Neck Surg 58:15–19Google Scholar

Copyright information

© Association of Otolaryngologists of India 2009

Authors and Affiliations

  • Jagruti A. Patel
    • 1
    Email author
  • Forum G. Shah
    • 1
  • Jagdish M. Kothari
    • 2
  • Kaustubh D. Patel
    • 2
  1. 1.Department of Pharmacology, Institute of PharmacyNirma University of Science and TechnologyAhmedabadIndia
  2. 2.Aastha Oncology AssociatesMedi-Surge HospitalsAhmedabadIndia

Personalised recommendations